DALVANCE
NDC 57970-100, Dalbavancin, injection, powder, for solution, from Allergan, Inc..
- Product NDC
- 57970-100
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021883
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57970-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALBAVANCIN HYDROCHLORIDE500 mg/25mL
Pharmacologic classes
Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57970-100-01 | 57970010001 | 1 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4b4674d8-4d1e-4728-8465-d42ada33fa5cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=57970-100
Use it
Look up 57970-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57970-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57970-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.